Progress in human ovarian rejuvenation: Current platelet-rich plasma and condensed cytokine research activity by scope and international origin
E. Scott Sills, Samuel H. Wood
Clin Exp Reprod Med. 2021;48(4):311-315.   Published online 2021 Nov 23     DOI:
Citations to this article as recorded by Crossref logo
Intraovarian condensed platelet cytokines for infertility and menopause—Mirage or miracle?
E. Scott Sills, Samuel H. Wood, Anthony P.H. Walsh
Biochimie.2023; 204: 41.     CrossRef
mTOR Inhibition via Low-Dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve?
E. Scott Sills, Conor Harrity, Samuel H. Wood, Seang Lin Tan
Journal of Personalized Medicine.2023; 13(7): 1147.     CrossRef
Nature and characteristics of global attention to research on article processing charges
Williams E. Nwagwu
The Journal of Academic Librarianship.2023; 49(6): 102808.     CrossRef
Beneficial effects of intraovarian injection of platelet-rich plasma in women with poor ovarian response
Aida Najafian, Ashraf Alyasin, Marziyeh Aghahosseini, Sedigheh Hosseinimousa, Seyyedeh Neda Kazemi
Clinical and Experimental Reproductive Medicine.2023; 50(4): 285.     CrossRef
Ovarian recovery via autologous platelet‐rich plasma: New benchmarks for condensed cytokine applications to reverse reproductive aging
E. Scott Sills
AGING MEDICINE.2022; 5(1): 63.     CrossRef
Platelet-rich plasma: inconclusive evidence of reproductive outcomes in menopausal women
Mira H. Kheil, Reem Bahsoun, Fady I. Sharara
Journal of Assisted Reproduction and Genetics.2022; 39(9): 1987.     CrossRef
Why might ovarian rejuvenation fail? Decision analysis of variables impacting reproductive response after autologous platelet-rich plasma
E. Scott SILLS
Minerva Obstetrics and Gynecology.2022;[Epub]     CrossRef
Epigenetics, ovarian cell plasticity, and platelet-rich plasma: Mechanistic theories
E Scott Sills, Samuel H Wood
Reproduction and Fertility.2022; 3(4): C44.     CrossRef